Navigate FDA Submission

Valion Bio

05/05/2026 13:33

May 5 (Reuters) - Valion Bio Inc VBIO.O:

VALION BIO RECEIVES FIRST FDA-PRECEDENT STUDY PROTOCOL FROM NIAID FOR ENTOLIMOD™; FEDERAL AGENCY TO FULLY FUND BLA-ENABLING IN VIVO PROGRAM AND CO-NAVIGATE FDA SUBMISSION

VALION BIO INC - NIAID TO FULLY FUND UP TO $7 MILLION IN VIVO STUDIES FOR ENTOLIMOD BLA

Source text: ID:nPn2v93j8a

Further company coverage: VBIO.O

 ((Reuters.Briefs@thomsonreuters.com;))